Clinical Trials on Plague, Pneumonic in China

Total 727 results

Ascletis Pharmaceuticals Co., Ltd.

Recruiting

Study to Evaluate Safety, Tolerability, PK and the Food Effect on PK of ASC11/RTV Tablets in Healthy Subjects

COVID-19 | Healthy

China
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Completed

the Safety and Efficacy of Meplazumab in Patients With COVID-19

Covid19

China
Southeast University, China

Completed

Effect of Prone Position onV/Q Matching in Non-intubated Patients With COVID-19

Covid19

China
Shanghai Henlius Biotech
Huashan Hospital; Shanghai Fosun Pharmaceutical Industrial Development Co.... and other collaborators

Recruiting

Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Ousehold in China

COVID-19

China
Shanghai Vinnerna Biosciences Co., Ltd.

Recruiting

A Real-world Retrospective Study of Disease Outcomes in Non-severe COVID-19 Patient

COVID-19 Patient

China
Xinqiao Hospital of Chongqing

Completed

A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease

COVID-19 Disease

China
Beijing Ditan Hospital

Completed

A Study of HH-120 Nasal Spray in Close Contacts of Those Diagnosed With COVID-19

COVID-19 | SARS-CoV-2 Infection

China
Frontier Biotechnologies Inc.

Completed

A Study of FB2001 for Inhalation in Healthy Chinese Adults

COVID-19 Pandemic

China
Guangzhou University of Traditional Chinese Medicine

Not yet recruiting

The Proteomic Study and Early Intervention Study of Carotid Unstable Plaque

Carotid Artery Plaque | Traditional Chinese Medicine | Protein; Disease

China
Shenzhen Kexing Pharmaceutical Co., Ltd.

Recruiting

Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19

COVID-19

China
Jiangsu Province Centers for Disease Control and...

Not yet recruiting

Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults

COVID-19

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

COVID-19

China
Sinocelltech Ltd.

Not yet recruiting

Study on the Antibody Level Against SARS-CoV-2 （COVID-19）in Dazhu County in 2023 (COVID-19)

COVID-19

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19

COVID-19

China
Chinese University of Hong Kong

Recruiting

COVID-19 Immunity and Changes Over Time

COVID-19

China
Sun Yat-sen University

Recruiting

Effectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination

COVID-19

China
WestVac Biopharma Co., Ltd.
West China Hospital

Not yet recruiting

Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents

COVID-19

China
Shenzhen Kangtai Biological Products Co., LTD
Beijing Minhai Biotechnology Co., Ltd; Hunan Provincial Center for Disease...

Not yet recruiting

Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 3 to 17 Years(COVID-19)

COVID-19

China
Jiangsu Province Centers for Disease Control and...
Academy of Military Medical Sciences，Academy of Military Sciences，PLA; ZHONGYIANKE... and other collaborators

Recruiting

Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)

COVID-19

China
Wuhan Union Hospital, China

Recruiting

Study on the Recovery of Pulmonary Function, Chest CT, Airway Microbiota, Hematologic, and Immune & Inflammatory Conditions in COVID-19 Rehabilitation Patients

COVID-19

China
Renmin Hospital of Wuhan University
Beijing SH Bio-Tech Corporation, Beijing (CN); Utooth Biological Technology...

Recruiting

Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients

COVID-19

China
Zhejiang ACEA Pharmaceutical Co. Ltd.

Completed

Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)

COVID-19

China
Sinovac Research and Development Co., Ltd.

Active, not recruiting

Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Aged 3-17 Years

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Completed

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Immunogenicity of an Inactivated COVID-19 Vaccine

COVID-19

China
Sinovac Biotech (Hong Kong) Limited

Completed

Immunogenicity and Safety Study of Booster Vaccine With the COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain

COVID-19

China
Xi'an International Medical Center Hospital

Completed

Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19)

COVID-19

China
Southeast University, China

Completed

Awaken Prone Positioning Ventinlation in COVID-19 Patients

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Afﬁliated Hospital of North Sichuan Medical College; Yantai Patronus Biotech...

Active, not recruiting

The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002

COVID-19

China
Institute of Biotechnology, Academy of Military...
Zhongnan Hospital; Jiangsu Province Centers for Disease Control and Prevention and other collaborators

Completed

A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) (CTII-nCoV)

COVID-19

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
First Affiliated Hospital Bengbu Medical College

Completed

Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell)

COVID-19

China
Seventh Medical Center of PLA General Hospital

Active, not recruiting

Evaluate the Safety and Immunogenicity of Ad5 COVID-19 Vaccines for Booster Use in Children Aged 6-17 Years.

COVID-19

China
Innovent Biologics (Suzhou) Co. Ltd.

Terminated

A Safety, Tolerability, and Efficacy Study of IBI314 in Patients With Mild to Moderate COVID-19

COVID-19

China
CanSino Biologics Inc.
Jiangsu Province Centers for Disease Control and Prevention; Beijing Institute...

Completed

Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation

COVID-19

China
CanSino Biologics Inc.
Jiangsu Province Centers for Disease Control and Prevention

Completed

A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups.

COVID-19

China
Jiangsu Province Centers for Disease Control and...

Active, not recruiting

Heterologous Boost Immunization With Ad5-nCoV After Three-dose Priming With an Inactivated SARS-CoV-2 Vaccine

COVID-19

China
Jiangsu Province Centers for Disease Control and...

Completed

Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine

COVID-19

China
Sinovac Biotech Co., Ltd

Active, not recruiting

Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivated Vaccine for Prevention of COVID-19

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)

COVID-19

China
CanSino Biologics Inc.
Tongji Hospital; Jiangsu Province Centers for Disease Control and Prevention; Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China and other collaborators

Completed

Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults (CTCOVID-19)

COVID-19

China
RenJi Hospital

Unknown

Long-term Outcomes in Patients With COVID-19

COVID-19

China
The University of Hong Kong

Unknown

Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19

COVID-19

China
Renmin Hospital of Wuhan University
Ansun Biopharma, Inc.

Completed

DAS181 for Severe COVID-19: Compassionate Use

COVID-19

China
Tongji Hospital

Unknown

A Pilot Study of Sildenafil in COVID-19

COVID-19

China
Ruijin Hospital

Recruiting

Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers

Covid19 | SARS-CoV-2 Infection

China
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

Completed

Phase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19

Mild to Moderate COVID-19

China
Ruijin Hospital

Recruiting

A Follow-up Study of Asymptomatic Infections and Diagnosed Patients With Covid-19 in Shanghai

COVID-19

China
Sinocelltech Ltd.

Completed

Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects

Coronavirus Disease 2019(COVID-19)

China

3

Subscribe